Applied Clinical Trials-09-01-2011

Issue PDF
Applied Clinical Trials

September 01, 2011

SUBJECT RECRUITMENT : Integrated Team - Sponsors, CROs, and Sites Patient Tracking Services Can Help Reduce Lost to Follow-Up TRIAL DESIGN : Pediatric Trials - Errors in Informed Consent Also in this issue : Common Rule Revision, EU?s Health Policy and Clinical Trials, CROs Going Private, Research Clusters

Applied Clinical Trials

A recent study conducted by the Tufts Center for the Study of Drug Development (Tufts CSDD) found that more than half of all protocols require one or more amendments.

Applied Clinical Trials
Feature Article

September 01, 2011

Sponsors, CROs, and investigator sites must all work together for effective patient recruitment.

Applied Clinical Trials
View from Washington

September 01, 2011

Modernizing the Common Rule to update research policies could spell important changes.

Applied Clinical Trials
Global News

September 01, 2011

The EMA is moving its offices to Canary Wharf Estate.

Applied Clinical Trials

Companies such as ExcoInTouch, Pfizer, and others are turning to mobile technology.

Applied Clinical Trials
A Closing Thought

September 01, 2011

While order might be useful for smaller firms to do business, it is not useful in helping them to innovate.

Applied Clinical Trials
Feature Article

September 01, 2011

A 10-fold reduction in LTFU rates was observed in clinical trials that used patient tracking services.

Applied Clinical Trials
Business News

September 01, 2011

Industry news focusing on the people and organizations who work in the clinical trials profession.

News
Applied Clinical Trials

September 01, 2011

Open Facebook walls could bombard companies with AERs.

News
Applied Clinical Trials

September 01, 2011

The New England Journal of Medicine reveals list of biosimilar guidelines.

Applied Clinical Trials
Feature Article

September 01, 2011

The intent of consent is that participants are comfortable with their choice and can comply with it.

Applied Clinical Trials
View from Brussels

September 01, 2011

EU's new rules will be influenced by more than just those primarily responsible for pharmaceuticals.